Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23158522

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2013 Jan 12
First author
Franz DN

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 Jan 12;381(9861):116
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2013 Jan 12;381(9861):95-6. doi: 10.1016/S0140-6736(12)61221-5.
    note
    Source null
    related pmid
    23158521
    relationship
    Comment in
  3. citation
    Nat Rev Neurol. 2013 Jan;9(1):6. doi: 10.1038/nrneurol.2012.257.
    note
    Source null
    related pmid
    23229407
    relationship
    Comment in
  4. citation
    Lancet. 2013 Apr 13;381(9874):1274-5. doi: 10.1016/S0140-6736(13)60836-3.
    note
    Source null
    related pmid
    23582392
    relationship
    Comment in
  5. citation
    Lancet. 2013 Apr 13;381(9874):1275. doi: 10.1016/S0140-6736(13)60837-5.
    note
    Source null
    related pmid
    23582393
    relationship
    Comment in

Authors and identifiers

  1. name
    Franz DN
    type
    Author
  2. name
    Belousova E
    type
    Author
  3. name
    Sparagana S
    type
    Author
  4. name
    Bebin EM
    type
    Author
  5. name
    Frost M
    type
    Author
  6. name
    Kuperman R
    type
    Author
  7. name
    Witt O
    type
    Author
  8. name
    Kohrman MH
    type
    Author
  9. name
    Flamini JR
    type
    Author
  10. name
    Wu JY
    type
    Author
  11. name
    Curatolo P
    type
    Author
  12. name
    de Vries PJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Franz DN
    type
    Author
  2. name
    Belousova E
    type
    Author
  3. name
    Sparagana S
    type
    Author
  4. name
    Bebin EM
    type
    Author
  5. name
    Frost M
    type
    Author
  6. name
    Kuperman R
    type
    Author
  7. name
    Witt O
    type
    Author
  8. name
    Kohrman MH
    type
    Author
  9. name
    Flamini JR
    type
    Author
  10. name
    Wu JY
    type
    Author
  11. name
    Curatolo P
    type
    Author
  12. name
    de Vries PJ
    type
    Author
bibliography ids
  1. nci-bib-9273f225d8228d8b7078b243
book metadata
content sha256
398e869a16b65d1d6846c72120eef5ff8ac2ec66209c0077167b1e6551b177b0
document type
citation
dois
  1. 10.1016/S0140-6736(12)61134-9
electronic publication date
display
2012 Nov 14
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:23158522
immutable id
pubmed:23158522@398e869a16b65d1d6846c72120eef5ff8ac2ec66209c0077167b1e6551b177b0
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9861
name
Lancet (London, England)
nlm unique id
2985213R
pages
125-32
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 Jan 12;381(9861):116
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2013 Jan 12;381(9861):95-6. doi: 10.1016/S0140-6736(12)61221-5.
    note
    Source null
    related pmid
    23158521
    relationship
    Comment in
  3. citation
    Nat Rev Neurol. 2013 Jan;9(1):6. doi: 10.1038/nrneurol.2012.257.
    note
    Source null
    related pmid
    23229407
    relationship
    Comment in
  4. citation
    Lancet. 2013 Apr 13;381(9874):1274-5. doi: 10.1016/S0140-6736(13)60836-3.
    note
    Source null
    related pmid
    23582392
    relationship
    Comment in
  5. citation
    Lancet. 2013 Apr 13;381(9874):1275. doi: 10.1016/S0140-6736(13)60837-5.
    note
    Source null
    related pmid
    23582393
    relationship
    Comment in
outcomes validated
false
pmid
23158522
provenance
batch id
99e85dbb34a1a3011c9a
provider
NCBI PubMed ESummary
record sha256
4545d85eedddb90d8c44fb3a21614b0ce0f445c6a7cc66a13cbe2d59f2398959
response sha256
1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
retrieved at
2026-09-09T23:46:52.860383+00:00
publication date
display
2013 Jan 12
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23158522/
title
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

Preserved source evidence · Not medical advice